ADB-BINACA
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
ADB-BINACA (also known as ADMB-BZINACA using EMCDDA naming standards ) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB 1 receptor with a binding affinity (K i ) of 0.33 nM and an EC 50 of 14.7 nM.
ADB-BINACA (also known as ADMB-BZINACA using EMCDDA naming standards ) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB 1 receptor with a binding affinity (K i ) of 0.33 nM and an EC 50 of 14.7 nM.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1340547498 under CC BY-SA 4.0; modifications have been made.